A Study to Evaluate the Immune Response to the ASP7373 and Its Safety in Healthy Adult Volunteers
Clinical trial NCT01450579 · COMPLETED
Trial details
- NCT number
- NCT01450579
- Sponsor
- UMN Pharma Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-01
- Primary completion
- 2011-12-01
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.